Embolx, Inc. — Form D
Embolx, Inc. of SUNNYVALE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-11-01. The offering totals $1.6M, of which $1.6M was reported sold. Industry: Other.
Offering
- Filed: 2022-11-01
- Form: D
- Accession: 0001601292-22-000003
- Industry: Other
- Exemptions: 06b
- Total offering: $1.6M
- Amount sold: $1.6M
- Investors: 5
- Date of first sale: 2022-10-19
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-463522
Issuer
- Name: Embolx, Inc.
- CIK: 0001601292
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Incorporated: 2013
- Address: 530 LAKESIDE DRIVE, SUNNYVALE, CA, 94085
- Phone: 408-990-2949
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Michael Allen | Director | Rochester, NY |
| NORMAN GITIS | Director | Sunnyvale, CA |
| FRANK GRILLO | Director | Sunnyvale, CA |
| PAUL ROGAN | Director | Sunnyvale, CA |
| TIANHONG XU | Director | Sunnyvale, CA |
| Michael Allen | Executive Officer | Rochester, NY |
| TOM BRETON | Executive Officer | Sunnyvale, CA |
| Michael Lin | Executive Officer | Santa Fe, NM |
| Michael P Allen | Director | Los Altos, CA |
| Michael P Allen | Executive Officer | Los Altos, CA |
| Paul F Rogan | Director | Santa Clara, CA |
| Robert JJ de Neve | Director | Santa Clara, CA |
| Robert JJ de Neve | Executive Officer | Santa Clara, CA |
Other filings by this issuer (4)
More